Pacira Biosciences Inc
F:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
Sibanye Stillwater Ltd
F:47V
|
ZA |
|
Novus Holdings Ltd
F:N09
|
ZA |
|
W
|
Wesco International Inc
XMUN:WP7
|
US |
|
M
|
MTU Aero Engines AG
XMUN:MTX
|
DE |
|
T
|
Transocean Ltd
F:TOJ
|
CH |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
|
Basf Se
XETRA:BAS
|
DE |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
M
|
Mizuho Financial Group Inc
XMUN:MZ8
|
JP |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
Grupo Aeroportuario del Sureste SAB de CV
F:AED
|
MX |
|
F
|
Fanuc Corp
DUS:FUC
|
JP |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
US |
|
A
|
Assicurazioni Generali SpA
XMUN:ASG
|
IT |
|
R
|
Radian Group Inc
SWB:RAG
|
US |
Bankruptcy Probability
Pacira Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pacira Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
910m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pacira Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pacira Biosciences Inc has total debt of 367.7m USD. This includes both short-term (0 USD) and long-term (367.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
